Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma


Afsar C. U. , Karabulut M., Karabulut S. , Alis H., Gonenc M., Dagoglu N., ...Daha Fazla

JOURNAL OF INFECTION AND CHEMOTHERAPY, cilt.23, ss.196-200, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 23
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.jiac.2016.12.003
  • Dergi Adı: JOURNAL OF INFECTION AND CHEMOTHERAPY
  • Sayfa Sayıları: ss.196-200

Özet

Background: This study was conducted to investigate the serum levels of interleukin-18 (IL-18) in patients with pancreatic adenocarcinoma (PA) and the relationship with tumor progression and known prognostic parameters.